Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

Donald Trump keeps bragging about “acing” a cognitive test, and last night, on Air Force One, insulted a reporter, saying she ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

The earlier Alzheimer’s disease can be diagnosed, the better the outcomes; however, it can be hard to diagnose the disease in its earliest stages. The United States Food and Drug Administration ...

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

-- At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other dementia. -- The ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...